Reduced Hypotonic Exposure and Sequential Membrane Cholesterol Enrichment Limit Phosphatidylserine Externalization and Enhance Circulatory Retention of Erythrocyte‐Derived Microparticles
Journal of Biomedical Materials Research Part A · 2026-06 · 114 (6)
DOI: 10.1002/jbm.a.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 15.06.2026. Verfasst von Shamima Zaman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of California, Riverside, Riverside, California, USA. Hauptthemen laut MEDLINE: Phosphatidylserines, Cholesterol, Erythrocytes, Cell-Derived Microparticles. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Erythrocyte‐derived carriers have emerged as effective biomimetic platforms for the delivery of therapeutic and imaging cargos. However, clearance by the mononuclear phagocytic system (MPS) limits their utility. Towards development of standardized methods for increased bioavailability, we have developed an approach that lowers the externalization of phosphatidylserine (PS), a biomarker for MPS clearance, to the outer leaflet of the membrane. Specifically, this approach minimizes the hypotonic treatment of erythrocytes to a single cycle for depleting the hemoglobin while enriching the membrane bilayer with cholesterol during depletion, and in the subsequent cargo loading step, using indocyanine green (ICG), a fluorescent probe as an illustrative cargo. Using this strategy, PS externalization remains limited to ~16% and 9% of the carrier system with and without the encapsulated ICG, respectively, compared to ~46%–99% following multiple hypotonic cycles without cholesterol enrichment. Carriers engineered using this method exhibit significantly reduced macrophage uptake in vitro. In vivo biodistribution studies in healthy mice show ~2.7‐fold increase in blood‐associated fluorescence, and ~3.3‐fold decrease in splenic accumulation after intravascular injection relative to carriers formed by multiple cycles of hypotonic treatment and without cholesterol enrichment. This method provides an effective approach to improve the circulatory retention of erythrocyte‐based carriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of California, Riverside, Riverside, California, USA.
ORCID-Profile: Grant Swajian, Shiril Bhardwaj Iragavarapu, Md Tashdid Hossain Shoudho, Bahman Anvari
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Zaman, S., Swajian, G., Iragavarapu, S. B., Shoudho, M. T. H., & Anvari, B. (2026). Reduced Hypotonic Exposure and Sequential Membrane Cholesterol Enrichment Limit Phosphatidylserine Externalization and Enhance Circulatory Retention of Erythrocyte‐Derived Microparticles. Journal of Biomedical Materials Research Part A, 114(6). https://doi.org/10.1002/jbm.a.70109
Vancouver
Zaman S, Swajian G, Iragavarapu SB, Shoudho MTH, Anvari B. Reduced Hypotonic Exposure and Sequential Membrane Cholesterol Enrichment Limit Phosphatidylserine Externalization and Enhance Circulatory Retention of Erythrocyte‐Derived Microparticles. Journal of Biomedical Materials Research Part A. 2026;114(6). doi:10.1002/jbm.a.70109
BibTeX
@article{Zaman2026,
author = {Zaman, Shamima and Swajian, Grant and Iragavarapu, Shiril Bhardwaj and Shoudho, Md Tashdid Hossain and Anvari, Bahman},
title = {Reduced Hypotonic Exposure and Sequential Membrane Cholesterol Enrichment Limit Phosphatidylserine Externalization and Enhance Circulatory Retention of Erythrocyte‐Derived Microparticles},
journal = {Journal of Biomedical Materials Research Part A},
year = {2026},
volume = {114},
number = {6},
doi = {10.1002/jbm.a.70109}
}
EUVIMED